Amniotic Membrane Wound Care Products in Baltimore, MD

What I’d check before adding amniotic membrane wound care here

Adult obesity in Baltimore is 38.1% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. CDC PLACES (2023, crude) estimates 14.4% of adults in Baltimore have diagnosed diabetes — 2.4 points above the U.S. 12% figure. Maryland is outside CDC’s core Diabetes Belt list; use the PLACES city rate anyway. Hawk Medical is the distributor for amniotic membrane wound care, not a walk-in clinic.

Where Baltimore programs actually stall

• CDC PLACES (2023, crude) estimates 14.4% of adults in Baltimore have diagnosed diabetes — 2.4 points above the U.S. 12% figure. Adult obesity in Baltimore is 38.1% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. A CTP without offloading and serial measurements still fails JL review. Product is the last step, not the first.
• Maryland Department of Health publishes state chronic-disease context that clinics can cite in patient education. Pair that with FDA 361 labeling — homologous use, minimal manipulation — so marketing does not outrun the product's actual regulatory lane.
• Population 585,708 (Census city proper) understates metro demand and overstates how many of those people will ever see a biologic. Use it as scale, then underwrite against clinic specialty mix.

Uninsured mix and Medicare CTPs in the same building

JL reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in Baltimore is 14.4% or not. PLACES is planning data. The LCD is the claim.

How we’d stand this up in clinic